5[1]Haffner Sn,Coazalez C,Uietnen H,et al.A prospective analysis of the Home mode[J].Diabetetes care 1996;19(10):1138-1141.
6[2]Fuhlendorff J Molecular identification of a specific binding site (36Kda)for repaglinide[J].Diabetes 1998;47:416-502.
7[3]Landgaf R.Bilo HJG Repaglinide vs glibendamide:a 14-weekefficacy and safety comparison[J].Diabetologia 1997;40(Suppl,1):321-326.
8[4]Moss R.A review of clinical expericrlce with the prandial glucose regulator.reaglinide,in the treatment of type 2 diabetes[J].Exert Opin harma Cother 2000;1:1455-1467.
